Loading…
Impact of Aberrant Myeloid Antigen Expression on Outcomes of Patients with T-Cell Acute Lymphoblastic Leukemia
Objectives: To evaluate the impact of myeloid antigen expression on complete remission (CR), event-free survival (EFS), and overall survival (OS) in patients with T-cell acute lymphoblastic leukemia (T-ALL) treated with intensive chemotherapy. Methods: We retrospectively reviewed consecutive patient...
Saved in:
Published in: | Oman medical journal 2017-05, Vol.32 (3), p.189-193 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Objectives: To evaluate the impact of myeloid antigen expression on complete remission
(CR), event-free survival (EFS), and overall survival (OS) in patients with T-cell acute
lymphoblastic leukemia (T-ALL) treated with intensive chemotherapy. Methods: We
retrospectively reviewed consecutive patients diagnosed with T-ALL and treated in Sultan
Qaboos University Hospital and Royal Hospital in Oman between 2004 and 2010.
The diagnosis of T-ALL was established using French-American-British classification or
World Health Organization criteria. Patients were considered having myeloid antigen
expression if they expressed CD13, CD33, or both (My+ and My–). Results: Of the 39
patients, 38 were included in the study (25 patients with My– and median age of 18.4
years, 13 patients with My+ and median age of 22.0 years). Median follow-up was 12
months. Thirty-two out of the total cohort were eligible for response-rate assessment.
Twenty-nine patients (90.6%) achieved CR with one or two courses of chemotherapy
with similar CR rates between the two groups (p = 0.880). Twenty-five percent (5/20)
of the patients with My– required two courses of induction, whereas 58.3% (7/12) of
My+ required two courses of induction and the difference was statistically significant
(p = 0.040). In the multivariable analysis; age, gender, initial white blood cell count,
central nervous system disease, and myeloid antigen expression were not statistically
significant predictors of CR. The EFS and OS were similar between the My+ and My–
groups p = 0.180 and p = 0.440, respectively. Conclusions: Patients with T-ALL with
myeloid antigen expression need more courses of induction; however, rates of CR,
EFS, and OS are not different from those without myeloid antigen expression. Larger
prospective studies are required to confirm these findings |
---|---|
ISSN: | 1999-768X 2070-5204 |
DOI: | 10.5001/omj.2017.36 |